181 related articles for article (PubMed ID: 22285309)
1. Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke.
Fernández-López D; Faustino J; Derugin N; Wendland M; Lizasoain I; Moro MA; Vexler ZS
Neuroscience; 2012 Apr; 207():307-15. PubMed ID: 22285309
[TBL] [Abstract][Full Text] [Related]
2. The Cannabinoid WIN 55,212-2 Reduces Delayed Neurologic Sequelae After Carbon Monoxide Poisoning by Promoting Microglial M2 Polarization Through ST2 Signaling.
Du JJ; Liu ZQ; Yan Y; Xiong J; Jia XT; Di ZL; Ren JJ
J Mol Neurosci; 2020 Mar; 70(3):422-432. PubMed ID: 31732924
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.
Zarruk JG; Fernández-López D; García-Yébenes I; García-Gutiérrez MS; Vivancos J; Nombela F; Torres M; Burguete MC; Manzanares J; Lizasoain I; Moro MA
Stroke; 2012 Jan; 43(1):211-9. PubMed ID: 22020035
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation.
Marchalant Y; Rosi S; Wenk GL
Neuroscience; 2007 Feb; 144(4):1516-22. PubMed ID: 17178196
[TBL] [Abstract][Full Text] [Related]
6. [Neuroprotective effect of preconditioning with cannabinoid receptor agonist WIN 55, 212 - 2 on focal cerebral ischemia: experiment with rats].
Chen Y; Chen SY; Wang Q; Sun J; Zhu ZH; Hou LC; Xiong LZ
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2219-22. PubMed ID: 19080676
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of WIN 55,212-2 pretreatment against focal cerebral ischemia through activation of extracellular signal-regulated kinases in rats.
Hu B; Wang Q; Chen Y; Du J; Zhu X; Lu Y; Xiong L; Chen S
Eur J Pharmacol; 2010 Oct; 645(1-3):102-7. PubMed ID: 20667450
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
9. Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats.
Chi OZ; Barsoum S; Grayson J; Hunter C; Liu X; Weiss HR
Pharmacology; 2012; 89(5-6):333-8. PubMed ID: 22678129
[TBL] [Abstract][Full Text] [Related]
10. WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats.
Sun J; Fang YQ; Ren H; Chen T; Guo JJ; Yan J; Song S; Zhang LY; Liao H
Acta Pharmacol Sin; 2013 Jan; 34(1):119-28. PubMed ID: 23202804
[TBL] [Abstract][Full Text] [Related]
11. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
12. Prospects for cannabinoid therapies in viral encephalitis.
Solbrig MV; Fan Y; Hazelton P
Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
[TBL] [Abstract][Full Text] [Related]
13. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia.
Martínez-Orgado J; Fernández-Frutos B; González R; Romero E; Urigüen L; Romero J; Viveros MP
Brain Res Mol Brain Res; 2003 Jun; 114(2):132-9. PubMed ID: 12829323
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.
Fernández-López D; Pazos MR; Tolón RM; Moro MA; Romero J; Lizasoain I; Martínez-Orgado J
Pediatr Res; 2007 Sep; 62(3):255-60. PubMed ID: 17622949
[TBL] [Abstract][Full Text] [Related]
16. The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxic-ischemic injury in fetal lambs.
Alonso-Alconada D; Alvarez FJ; Alvarez A; Mielgo VE; Goñi-de-Cerio F; Rey-Santano MC; Caballero A; Martinez-Orgado J; Hilario E
Brain Res; 2010 Nov; 1362():150-9. PubMed ID: 20858469
[TBL] [Abstract][Full Text] [Related]
17. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Epilepsy Res; 2016 May; 122():56-65. PubMed ID: 26970948
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
Zawadzka M; Kaminska B
Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
